CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Sagar Bhosale

Reviews

IOL CHEMICALS AND PHARMACEUTICALS LTD. 

Ticker : 524164
FV: Rs10
52-Week H/L: Rs234.90/108 


We had recommended IOL Chemicals and Pharmaceuticals in volume no. 35, issue no. 39 (dated July 22, 2019), when the scrip was trading at Rs. 213.30. The company is a leading organic chemicals manufacturer and supplier in India. It manufactures active pharmaceutical ingredients, organic chemicals and intermediates and also manufactures and supplies industrial chemicals and bulk drugs for use in various pharmaceutical applications. On the financial front, the company’s net income went up by 36 per cent to Rs 496 crore in Q1FY20 as compared to Rs 365 crore posted in Q1FY29. The EBIDTA for Q1FY20 was Rs 148 crore, posting a substantial increase of 244 per cent as compared to EBIDTA of Rs 43 crore for Q1FY19. The net profit rose by 507 per cent to Rs 85 crore in Q1FY20 from Rs 14 crore in Q1FY19. The company had recently announced pre-payment of a long-term loan, thus reducing the company’s debt. Based on our analysis, we recommend a HOLD.

Previous Article Technicals
Next Article Fundamentals
Print
63 Rate this article:
No rating
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR